Clinical Trials Directory

Trials / Unknown

UnknownNCT03166943

the Possible Effect of the Antiviral Inhibitors for Treatment of Hepatitis C Virus Infection in Cardiac Function

An Investigative Study on the Possible Effect of the Antiviral Inhibitors (Sofosbuvir and Daclatasvir) for Treatment of Hepatitis C Virus Infection in Cardiac Function

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
130 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

It has been known for many years that the heart and the liver are intimately related. There is a mutual interaction between the function of the heart and the liver and a broad spectrum of acute and chronic entities that affect both the heart and the liver. Chronic hepatitis C virus infection affects more than 3% (170 million) of the world's population.

Detailed description

Assessment of systolic function by echocardiography will be done to 100 hepatitis C virus infected patients who receive antiviral treatment (sofosbuvir and daclatasvir) by biplane simpson's method and by speckle tracking. Assessment of diastolic function by echocardiography to 30 hepatitis C virus infected patients who will not receive antiviral treatment, by left atrium volume , mitral inflow pattern , tissue doppler annular early and late diastolic velocities .

Conditions

Interventions

TypeNameDescription
PROCEDURESystolic function by echocardiographyEchocardiography for evaluation of systolic function: * by biplane Simpson's method. * by speckle tracking:
PROCEDUREDiastolic function by echocardiographyEchocardiography for evaluation of diastolic function: * Left atrial Volume * Mitral Inflow Patterns * Pulsed wave Doppler * Mitral inflow patterns include normal, impaired left ventricular relaxation, pseudonormal, and restrictive left ventricular filling patterns. * Tissue Doppler Annular Early and Late Diastolic Velocities * Pulsed wave tissue doppler imaging * Primary measurements include the systolic , early diastolic, and late diastolic velocities.

Timeline

Start date
2017-05-10
Primary completion
2020-12-01
Completion
2020-12-01
First posted
2017-05-25
Last updated
2020-01-22

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03166943. Inclusion in this directory is not an endorsement.